Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension

Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension

Abstract Objective To explore the effects of long-term oral ACEIs/ARBs on the incidence of exacerbation and in-hospital mortality in elderly COVID-19 Omicron BA.2 patients with hypertension, especially patients aged 80 years or older. Materials and methods In this retrospective study, patients suffe...

Full description

Bibliographic Details
Main Authors: Zhe Zhang, Shengyong Wu, Zhiyong Wang, Yue Wang, Hui Chen, Cheng Wu, Lize Xiong
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Infectious Diseases
Subjects:
Angiotensin-converting enzyme inhibitors
Angiotensin receptor antagonists
COVID-19
Hypertension
Aged patients
Online Access:https://doi.org/10.1186/s12879-023-08913-6

Internet

https://doi.org/10.1186/s12879-023-08913-6

Similar Items